ATOMT — Atomtrace as Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Atomtrace as, fiscal year end - December 31st, CZK millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.81 | -8.36 | -16.9 | -20.2 | -18.4 |
| Depreciation | |||||
| Non-Cash Items | 0.129 | -0.247 | 0.027 | 0.463 | 0.285 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.87 | 1.21 | 0.098 | 0.598 | 5.79 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.53 | -7.18 | -16.5 | -18.9 | -12.2 |
| Capital Expenditures | -0.17 | -0.47 | -0.1 | -0.1 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.372 | — | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.17 | -0.098 | -0.1 | -0.1 | 0 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8.03 | 0.016 | 17.3 | 20.7 | 11.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.336 | -7.27 | 0.667 | 1.77 | -1.02 |